Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance to antiretroviral agents in individuals with HIV-1 non-B subtypes.

HIV clinical trials - 1 Jan 2000

Holguín Africa, Soriano Vincent

Abstract excerpt

Naturally occurring polymorphisms at positions involved in resistance to antiretroviral agents are frequently seen in HIV-1 non-B subtypes. Although they do not seem to affect significantly the susceptibility to antiretroviral drugs in vitro, they may facilitate the selection of different pathways and/or a more rapid emergence of drug resistance and treatment failure under not fully suppressive treatment regimens.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Multiple, Viral
Share to Evolution, Molecular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to HIV Infections

Share to Mutation

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 12407490
DOI: 10.1310/7bwp-0x7f-nxna-qrnp

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance to antiretroviral agents in individuals with HIV-1 non-B subtypes.PMID 12407490Read ↗

The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral DrugsSemantic proximity Read ↗

Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.Semantic proximity Read ↗

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral DrugsSemantic proximity Read ↗

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Semantic proximity Read ↗

Drug resistance in non-subtype B HIV-1.Semantic proximity Read ↗

Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.Semantic proximity Read ↗

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom.Semantic proximity Read ↗

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.Semantic proximity Read ↗

Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical ManagementSemantic proximity Read ↗

Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.Semantic proximity Read ↗

HIV-1 non-B resistance mutations and natural polymorphisms to integrase strand transfer inhibitors in recently diagnosed patients in Gabon, Central Africa.Semantic proximity Read ↗

Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.